Hansoh Pharmaceutical Group Company Ltd

3692.HK · Health Technology · Pharmaceuticals: Major · CN

9,178 employees · hspharm.com

About

The Hansoh Pharmaceutical Group Co Ltd is a leading company in the pharmaceutical industry in China. It was founded in 1995 and has its headquarters in Lianyungang, with branches in Beijing and Shanghai. The company specializes in developing and producing innovative drugs for various diseases. It invests significant resources in research and development, collaborating with renowned research institutes and universities. Hansoh has a wide range of products in areas such as oncology, anesthesia, antibiotics, anti-infectives, and cardiovascular diseases. It has expanded its research and development activities in recent years and has partnerships with other pharmaceutical companies. The company mainly sells its products to hospitals and medical facilities in China. It is committed to strong corporate governance and sustainability, and it has been recognized for its environmental initiatives. Overall, Hansoh Pharmaceutical Group Co Ltd is a major player in the Chinese pharmaceutical industry.

Annual results

Reported figures, CNY · revenue up 42.7% in 2025

YearRevenueNet incomeNet marginFree cash flow
202517.5B6.5B37.0%—
202412.3B4.4B35.7%—
202310.1B3.3B32.4%—
202210.9B3.0B27.5%—
202111.6B3.2B27.3%—

Dividends per share

2026 0.20 CNY2025 0.37 CNY2024 0.37 CNY2023 0.12 CNY2022 0.23 CNY

3692.HK in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Hansoh Pharmaceutical Group Company Ltd are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Hansoh Pharmaceutical Group Company Ltd (3692.HK) — company profile and financials · MarketPulse